Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    Antibiotic Targets Genetic Signature of Specific Bacteria Strains

    By Global Biodefense StaffJanuary 30, 2014
    Share
    Facebook LinkedIn Reddit Email
    Staphylococcus aureus bacteria (NIAID RML)
    Credit: NIAID

    Researchers have developed a de facto antibiotic “smart bomb” that can identify specific strains of bacteria and sever their DNA, eliminating the infection. The technique offers a potential approach to treat infections by multi-drug resistant bacteria.

    “Conventional antibiotic treatments kill both ‘good’ and ‘bad’ bacteria, leading to unintended consequences, such as opportunistic infections,” says Dr. Chase Beisel, an assistant professor of chemical and biomolecular engineering at NC State and senior author of a paper describing the work. “What we’ve shown in this new work is that it is possible to selectively remove specific strains of bacteria without affecting populations of good bacteria.”

    The new approach works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When those CRISPR RNAs find a match, they unleash Cas proteins that cut the DNA.

    The NC State researchers have demonstrated that designing CRISPR RNAs to target DNA sequences in the bacteria themselves causes bacterial suicide, as a bacterium’s CRISPR-Cas system attacks its own DNA.

    “In lab testing, we found that this approach removes the targeted bacteria,” Beisel says. “We’re still trying to understand precisely how severing the DNA leads to elimination of the bacteria. However, we’re encouraged by the ease in specifically targeting different bacteria and the potency of elimination.”

    The researchers tested the approach in controlled cultures with different combinations of bacteria present, and were able to eliminate only the targeted strain. “For example, we were able to eliminate Salmonella in a culture without affecting good bacteria normally found in the digestive tract,” Beisel says.

    The researchers were also able to demonstrate the precision of the technique by eliminating one strain of a species, but not another strain of the same species which shares 99 percent of the same DNA.

    Another benefit of the approach, Beisel says, is that “by targeting specific DNA strands through the CRISPR-Cas system, we’re able to bypass the mechanisms underlying the many examples of antibiotic resistance.”

    The researchers are currently working to develop effective methods for delivering the CRISPR RNAs in clinical settings.

    “This sets the stage for next-generation antibiotics using programmable CRISPR-Cas systems,” says Dr. Rodolphe Barrangou, an associate professor of food, bioprocessing and nutrition sciences at NC State and co-author of the manuscript.

    Read the paper at mBio: Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems.

    Antimicrobials Salmonella
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleResearchers Find Novel Approach for Controlling Deadly C. diff Infections
    Next Article SPARTA Project to Assess Mechanisms of Chemical and Biological Agents

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Case Study: Fatal Avian Influenza Infection in Cat in Poland

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.